Generic Drug Battles Heat Up

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2005, Volume 29, Issue 4

Innovators and generics makers are staking out positions on follow-on proteins and other manufacturing issues.

Related Content:

Bio/Pharma BusinessManufacturingQuality SystemsRegulatory WatchGeneric DrugsDosage FormsPharmaceutical Technology-04-02-2005
FDA Rare Disease Innovation Moves Forward
Denmark’s First AI Supercomputer for Drug Discovery Now Operational Under Novo Nordisk Foundation Commitment
Lilly and ViaNautis Bio Partner on Development of Novel Therapeutics Delivering Genetic Cargo